# EDGAR Filing Document

**Accession Number:** 0001534133
**File Stem:** 0001193125-26-098556
**Filing Date:** 2026-3
**Character Count:** 2782
**Document Hash:** fc6a83f3d5d345efdd547a5fb0b402a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-098556.hdr.sgml**: 20260408

**ACCESSION NUMBER**: 0001193125-26-098556

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CalciMedica, Inc.
- **CENTRAL INDEX KEY:** 0001534133
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 452120079
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 505 COAST BOULEVARD SOUTH
- **STREET 2:** SUITE 307
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037
- **BUSINESS PHONE:** 858-952-5500

**MAIL ADDRESS:**
- **STREET 1:** 505 COAST BOULEVARD SOUTH
- **STREET 2:** SUITE 307
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CalciMedica, Inc. /DE/
- **DATE OF NAME CHANGE:** 20230322

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG VISION, INC.
- **DATE OF NAME CHANGE:** 20170717

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG, Inc.
- **DATE OF NAME CHANGE:** 20150303

**CALCIMEDICA, INC.** 

**505 Coast Boulevard South, Suite 307** 

**La Jolla, CA 92037** 

March 9, 2026

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren S. Hamill

---

| | |
|:---|:---|
| RE: | **CalciMedica, Inc.**  |

---

**Registration Statement on Form S-3** 

**File No. 333-293972** 

Ladies and Gentlemen:

CalciMedica, Inc. (the "***Registrant***") hereby requests that the U.S. Securities and Exchange Commission (the "***Commission***") take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on March 11, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Brittany Wightman of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Brittany Wightman of Cooley LLP at (858) 550-6132.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **CALCIMEDICA, INC.** | **CALCIMEDICA, INC.** |
| By: | /s/ A. Rachel Leheny, Ph.D. |
| Name: | A. Rachel Leheny, Ph.D. |
| Title: | Chief Executive Officer |
| cc: | John Dunn, CalciMedica, Inc. |
|  | Carlos Ramirez, Cooley LLP |
|  | Brittany Wightman, Cooley LLP |

---